Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 972 shares at $14.79 ($14K) on 2026-04-28, disclosed to the SEC on 2026-04-30.
Open-market sale of $14k RLAY by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $3.2M | — | Filing → |